This publication is provided for historical reference only and the information may be out of date.
In designing the study questions and methodology at the outset of this report, the EPC consulted several technical and content experts. Broad expertise and perspectives were sought. Divergent and conflicted opinions are common and perceived as healthy scientific discourse that results in a thoughtful, relevant systematic review. Therefore, in the end, study questions, design, methodologic approaches, and/or conclusions do not necessarily represent the views of individual technical and content experts.
Technical Experts must disclose any financial conflicts of interest greater than $10,000 and any other relevant business or professional conflicts of interest. Because of their unique clinical or content expertise, individuals with potential conflicts may be retained. The TOO and the EPC work to balance, manage, or mitigate any potential conflicts of interest identified.
The list of Technical Experts who participated in developing this report follows:
- Michael Choti, M.D., M.B.A.Professor of SurgeryJohns Hopkins UniversityBaltimore, MD
- Steven Curley, M.D.Professor of Surgical OncologyMD Anderson Cancer CenterHouston, TX
- Jean-Francois Geschwind, M.D.Professor of Radiology, Surgery and OncologyDirector, Vascular and Interventional RadiologyDirector, Interventional Radiology CenterJohns Hopkins UniversityBaltimore, MD
- Ahmed Kaseb, M.D.Assistant ProfessorGastrointestinal Medical OncologyMD Anderson Cancer CenterHouston, TX
- Robert Lewandowski, M.D.Assistant Professor of RadiologyNorthwestern University Feinberg School of MedicineChicago, IL
- John Yao, M.D.Senior Medical DirectorBlue Shield of CaliforniaLodi, CA
Publication Details
Copyright
Publisher
Agency for Healthcare Research and Quality (US), Rockville (MD)
NLM Citation
Belinson S, Yang Y, Chopra R, et al. Local Therapies for Unresectable Primary Hepatocellular Carcinoma [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 May. (Comparative Effectiveness Reviews, No. 114.) Technical Expert Panel.